Neuropathix, Inc. Stock
Equities
NPTX
US64132Q1094
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Dean Petkanas
CEO | Chief Executive Officer | 60 | 18-07-24 |
Mark Corrao
DFI | Director of Finance/CFO | 67 | 18-07-24 |
William Kinney
CTO | Chief Tech/Sci/R&D Officer | 66 | 18-07-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Malasek
BRD | Director/Board Member | 55 | 17-06-19 |
Timothy Scott
BRD | Director/Board Member | 71 | 18-07-24 |
Dean Petkanas
CEO | Chief Executive Officer | 60 | 18-07-24 |
1st Jan change | Capi. | |
---|---|---|
+19.44% | 125B | |
+20.01% | 114B | |
+21.11% | 26.73B | |
-23.72% | 19.43B | |
-18.17% | 16.22B | |
-19.87% | 15.33B | |
+55.81% | 14.2B | |
+8.76% | 14.42B | |
-48.79% | 14.33B |